Effect of antacid and H2 receptor antagonists on the intestinal absorption of folic acid
- PMID: 2902178
Effect of antacid and H2 receptor antagonists on the intestinal absorption of folic acid
Abstract
Intestinal folic acid transport is a saturable process with a pH optimum of 5.5 to 6.0. Because of the possible effects of antacids and acid-lowering drugs on the pH of the proximal small intestine, the influence of these drugs on folic acid absorption was studied by using tritium-labeled pteroylmonoglutamic acid (PGA) in 30 subjects (21 women, nine men) of 56 to 89 years of age. Both cimetidine and an antacid containing aluminum and magnesium hydroxide reduced folate absorption from a liquid formula meal (p less than 0.01, p less than 0.001, respectively). Although ranitidine also caused a fall in folic acid absorption from the liquid meal, the change was not statistically significantly different from when PGA was given with the meal alone. Both histamine receptor antagonists tended to maintain a high intraluminal pH in the proximal small intestine after meals, which in part could explain the inhibition of folate absorption. However, neither drug was found to chemically interact with folic acid, and neither drug inhibited the dihydrofolate reductase. The antacid was found to precipitate folic acid at a pH of greater than 4.0, thus removing it from the aqueous phase. This appears to be the explanation for the lowered folate absorption in the presence of antacid. Although the effects of these drugs on reducing folic acid absorption were relatively small, such reductions could become clinically significant in chronic antacid or H2 receptor antagonist use or intensive antacid or H2 receptor antagonist use by individuals eating diets that are marginal in folate content.
Similar articles
-
Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.Int J Clin Pharmacol Ther. 1997 Jun;35(6):261-4. Int J Clin Pharmacol Ther. 1997. PMID: 9208343 Clinical Trial.
-
Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects.J Clin Pharmacol. 2006 May;46(5):549-58. doi: 10.1177/0091270006286904. J Clin Pharmacol. 2006. PMID: 16638738 Clinical Trial.
-
The influence of H2 receptor antagonists on the plasma concentrations of midazolam and temazepam.Eur J Anaesthesiol. 1984 Sep;1(3):245-51. Eur J Anaesthesiol. 1984. PMID: 6152615 Clinical Trial.
-
Histamine H2-antagonist drug interactions in perspective: mechanistic concepts and clinical implications.Am J Med. 1984 Nov 19;77(5B):57-84. Am J Med. 1984. PMID: 6150639 Review.
-
Effects of antacids on the clinical pharmacokinetics of drugs. An update.Clin Pharmacokinet. 1990 Mar;18(3):210-9. doi: 10.2165/00003088-199018030-00003. Clin Pharmacokinet. 1990. PMID: 1969784 Review.
Cited by
-
Mechanisms of membrane transport of folates into cells and across epithelia.Annu Rev Nutr. 2011 Aug 21;31:177-201. doi: 10.1146/annurev-nutr-072610-145133. Annu Rev Nutr. 2011. PMID: 21568705 Free PMC article. Review.
-
Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.Expert Rev Mol Med. 2009 Jan 28;11:e4. doi: 10.1017/S1462399409000969. Expert Rev Mol Med. 2009. PMID: 19173758 Free PMC article. Review.
-
Potential vitamin-drug interactions in children: at a pediatric emergency department.Paediatr Drugs. 2009;11(4):251-7. doi: 10.2165/00148581-200911040-00004. Paediatr Drugs. 2009. PMID: 19566109
-
Scientific opinion on the tolerable upper intake level for folate.EFSA J. 2023 Nov 13;21(11):e08353. doi: 10.2903/j.efsa.2023.8353. eCollection 2023 Nov. EFSA J. 2023. PMID: 37965303 Free PMC article.
-
Clinically important drug interactions with zopiclone, zolpidem and zaleplon.CNS Drugs. 2003;17(7):513-32. doi: 10.2165/00023210-200317070-00004. CNS Drugs. 2003. PMID: 12751920 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical